Expanded immune imprinting and neutralization spectrum by hybrid immunization following breakthrough infections with SARS-CoV-2 variants after three-dose vaccination
Open Access
- 26 November 2024
- journal article
- research article
- Published by Elsevier in Journal of Infection
- Vol. 89 (6) , 106362
Abstract
No abstract availableKeywords
Funding Information
- Science, Technology and Innovation Commission of Shenzhen Municipality (20200825113322001, GXWD20201231165807008)
- Guangdong Provincial Applied Science and Technology Research and Development Program (2019B030301009)
- National Natural Science Foundation of China (82041043)
- Science and Technology Program of Gansu Province
- National Key Research and Development Program of China (2021YFC2300100)
- Chinese Academy of Meteorological Sciences
- CAMS Innovation Fund for Medical Sciences (2022-I2M-1-021)
This publication has 56 references indexed in Scilit:
- Immune escape of BA.2.86 is comparable to XBB subvariants from the plasma of BA.5‐ and BA.5‐XBB‐convalescent subpopulationsJournal of Medical Virology, 2024
- Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variantsCell, 2024
- COVID-19: From emerging variants to vaccinationCytokine & Growth Factor Reviews, 2023
- Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine boosterCell Host & Microbe, 2023
- Sequential reinfection with Omicron variants elicits broader neutralizing antibody profiles in booster vaccinees and reduces the duration of viral sheddingJournal of Medical Virology, 2023
- Stable and durable antibody responses in SARS‐recovered donors vaccinated with inactivated SARS‐CoV‐2 vaccineJournal of Medical Virology, 2023
- Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination historyCell Host & Microbe, 2022
- Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serumCell, 2022
- Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variantsCell, 2022
- Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta VariantsJAMA, 2022